Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge A Roman-Blas

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
International Reviews of Immunology|October 15, 2008
Targeting NF-kappaB: a promising molecular therapy in inflammatory arthritisJorge A Roman-Blas, Sergio A Jimenez
Arthritis Research & Therapy|February 10, 2015
Targeting subchondral bone in osteoporotic osteoarthritisJorge A Roman-Blas, Gabriel Herrero-Beaumont
Nature Reviews. Rheumatology|July 17, 2013
Osteoarthritis: Osteoporotic OA: a reasonable target for bone-acting agentsGabriel Herrero-Beaumont, Jorge A Roman-Blas
Rheumatology (Oxford, England)|July 28, 2018
Does anti-tumour necrosis factor alpha therapy exert a long-term structural benefit in hand osteoarthritis?Jorge A Roman-Blas, Helen Keen, Gabriel Herrero-Beaumont
Biochemical Pharmacology|October 4, 2011
Subchondral bone as a key target for osteoarthritis treatmentSantos Castañeda, Jorge A Roman-Blas, Raquel Largo, et al.
Arthritis Research & Therapy|October 7, 2009
Osteoarthritis associated with estrogen deficiencyJorge A Roman-Blas, Santos Castañeda, Raquel Largo, et al.
Arthritis Care & Research|June 18, 2010
Efficacy and safety of a selective estrogen receptor β agonist, ERB-041, in patients with rheumatoid arthritis: a 12-week, randomized, placebo-controlled, phase II studyJorge A Roman-Blas, Santos Castañeda, Maurizio Cutolo, et al.
Rheumatology (Oxford, England)|July 24, 2013
Osteoarthritis: a progressive disease with changing phenotypesSantos Castañeda, Jorge A Roman-Blas, Raquel Largo, et al.
Seminars in Arthritis and Rheumatism|July 11, 2009
Primary osteoarthritis no longer primary: three subsets with distinct etiological, clinical, and therapeutic characteristicsGabriel Herrero-Beaumont, Jorge A Roman-Blas, Santos Castañeda, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 14, 2017
ReplyJorge A Roman-Blas, Olga Sánchez-Pernaute, Raquel Largo, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
International Reviews of Immunology|October 15, 2008
Targeting NF-kappaB: a promising molecular therapy in inflammatory arthritisJorge A Roman-Blas, Sergio A Jimenez
Arthritis Research & Therapy|February 10, 2015
Targeting subchondral bone in osteoporotic osteoarthritisJorge A Roman-Blas, Gabriel Herrero-Beaumont
Nature Reviews. Rheumatology|July 17, 2013
Osteoarthritis: Osteoporotic OA: a reasonable target for bone-acting agentsGabriel Herrero-Beaumont, Jorge A Roman-Blas
Rheumatology (Oxford, England)|July 28, 2018
Does anti-tumour necrosis factor alpha therapy exert a long-term structural benefit in hand osteoarthritis?Jorge A Roman-Blas, Helen Keen, Gabriel Herrero-Beaumont
Biochemical Pharmacology|October 4, 2011
Subchondral bone as a key target for osteoarthritis treatmentSantos Castañeda, Jorge A Roman-Blas, Raquel Largo, et al.
Arthritis Research & Therapy|October 7, 2009
Osteoarthritis associated with estrogen deficiencyJorge A Roman-Blas, Santos Castañeda, Raquel Largo, et al.
Arthritis Care & Research|June 18, 2010
Efficacy and safety of a selective estrogen receptor β agonist, ERB-041, in patients with rheumatoid arthritis: a 12-week, randomized, placebo-controlled, phase II studyJorge A Roman-Blas, Santos Castañeda, Maurizio Cutolo, et al.
Rheumatology (Oxford, England)|July 24, 2013
Osteoarthritis: a progressive disease with changing phenotypesSantos Castañeda, Jorge A Roman-Blas, Raquel Largo, et al.
Seminars in Arthritis and Rheumatism|July 11, 2009
Primary osteoarthritis no longer primary: three subsets with distinct etiological, clinical, and therapeutic characteristicsGabriel Herrero-Beaumont, Jorge A Roman-Blas, Santos Castañeda, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 14, 2017
ReplyJorge A Roman-Blas, Olga Sánchez-Pernaute, Raquel Largo, et al.
Pageof 3